We validated gCap expression of CXCL12 in COPD by performing in situ hybridization for CXCL12 mRNA and immunostaining for PRX and NOSTRIN (Fig. 5D, Supplemental Fig. 22). This evidence concerns the gene PRX and chronic obstructive pulmonary disease.